Acelrx pharmaceuticals reports second quarter 2021 financial results

Hayward, calif., aug. 16, 2021 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quarter 2021 financial results.
ACRX Ratings Summary
ACRX Quant Ranking